Nov 28, 2023 / 03:50PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics Team
Hello everyone. Thank you for joining us this morning. Pleasure to have with us Illumina. From the company, we have CFO, Joydeep Goswami and from Investor Relations, we have Salli. And I'm Vijay Kumar. I cover life science tools, medtech.
Questions and Answers:
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD and Head of Medical Supplies & Devices and Life Science Tools & Diagnostics TeamBut maybe just diving right into it, Joydeep. This has been a pretty remarkable year for Illumina. Shares are down 50% -- off 80% from the peak. When I think about the macro, clearly that's been challenging but obviously Illumina has had its own set of issues. I think I want to start with us -- with some of the bear debates that I have been -- questions I've been getting, right? I think one of the questions has been, look, Illumina launched a new
Trustpilot
